Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment

被引:0
作者
Fusheng Bai
Hong Peng
Joseph D. Etlinger
Richard J. Zeman
机构
[1] New York Medical College,Department of Cell Biology and Anatomy
[2] MotoGen Inc,undefined
来源
Pflügers Archiv - European Journal of Physiology | 2010年 / 460卷
关键词
Spinal cord injury; Axonal regrowth; Locomotor function; Chondroitinase; Clenbuterol;
D O I
暂无
中图分类号
学科分类号
摘要
Spinal cord injury not only disrupts axonal tracts but also causes gliotic, fibrotic, and Schwannotic scarring with resulting deposition of chondroitin sulfate proteoglycans (CSPGs) which prevent axonal reconnection and recovery of locomotor function. Here, we determined whether recovery of locomotor function could be promoted after complete transection, by degrading CSPGs enzymatically within the injury site with chondroitinase ABC (chABC) together with treatment with the β2-adrenoceptor agonist, clenbuterol, a neuroprotective agent which can promote regrowth of lower motoneurons. Partial recovery of locomotor function was observed 8–12 weeks postinjury only after combined chABC and clenbuterol treatment. The recovery of locomotor function coincided with the presence of axons caudal to the injury site arising from neurons of the reticular, vestibular, and red nuclei also only with combined chABC and clenbuterol treatment. Axons myelinated by Schwann cells were most prominent in the transection site in the combined treatment group. Clenbuterol treatment activated cAMP response element binding protein within retrogradely traced neurons which has been associated with axonal regrowth. ChABC treatment decreased scarring due to both CSPG and collagen deposition as well as the gap between intact regions of the spinal cord. ChABC also increased numbers of phagocytic cells which remove myelin debris as well as populations of astrocytes thereby aiding blood–spinal cord barrier reformation. Together the results suggest that chABC and clenbuterol can act synergistically to promote recovery of locomotor function.
引用
收藏
页码:657 / 666
页数:9
相关论文
共 124 条
  • [11] Kraydieh S(1999)Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage Eur J Pharmacol 379 33-45
  • [12] Caggiano AO(1995)The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury Exp Neurol 132 220-228
  • [13] Zimber MP(2005)Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord J Neurosci 25 1169-1178
  • [14] Ganguly A(2001)Regeneration of peripheral nerves after clenbuterol treatment in a rat model Muscle Nerve 24 1687-1691
  • [15] Cai D(2004)Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo Neuron 44 609-621
  • [16] Qiu J(2004)Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice J Neurosci 24 10064-10073
  • [17] Cao Z(2000)Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion J Neurosci 20 6421-6430
  • [18] Cao Z(2003)The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury Exp Neurol 182 399-411
  • [19] Gao Y(2002)Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection Eur J Pharmacol 446 25-36
  • [20] Bryson JB(2008)Noradrenergic stimulation of BDNF synthesis in astrocytes: mediation via alpha1- and beta1/beta2-adrenergic receptors Neurochem Int 52 297-306